BMC Cancer
Journal Abbreviation: BMC CANCER
ISSN: 1471-2407
Publisher: BioMed Central
Publications (99)
Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects (2018)
Munker S, Gerken M, Fest P, Ott C, Schnoy E, Fichtner-Feigl S, Wiggermann P, et al.
Journal article
Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17-ARO 2016/3-DKTK ROG trial) (2018)
Straube C, Scherb H, Gempt J, Kirschke J, Zimmer C, Schmidt-Graf F, Meyer B, Combs SE
Journal article
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients (2018)
Hübner H, Fasching P, Gumbrecht W, Jud S, Rauh C, Matzas M, Paulicka P, et al.
Journal article
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer (2018)
Banys-Paluchowski M, Fehm T, Janni W, Aktas B, Fasching P, Kasimir-Bauer S, Milde-Langosch K, et al.
Journal article
Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients (2018)
Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching P, Fehm T, et al.
Journal article
Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial (2018)
Schink K, Herrmann HJ, Schwappacher R, Meyer J, Orlemann T, Waldmann E, Wullich B, et al.
Journal article
ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro (2018)
Schmid R, Wolf K, Robering JW, Strauss S, Strissel P, Strick R, Rübner M, et al.
Journal article
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer (2018)
Gaß P, Lux MP, Rauh C, Hein A, Bani M, Fießler C, Hartmann A, et al.
Journal article
Galectin 3 expression in regional lymph nodes and lymph node metastases of oral squamous cell carcinomas (2018)
Wehrhan F, Büttner-Herold M, Distel L, Ries J, Möbius P, Preidl R, Geppert CI, et al.
Journal article
Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria (2018)
Hoyer J, Vasileiou G, Uebe S, Wunderle M, Kraus C, Fasching P, Thiel C, et al.
Journal article